- Home
- MHK vs ASND Comparison
MHK vs ASND Comparison
Compare MHK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- ASND
- Stock Information
- Founded
- MHK 1988
- ASND 2006
- Country
- MHK United States
- ASND Denmark
- Employees
- MHK N/A
- ASND N/A
- Industry
- MHK Home Furnishings
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- MHK Consumer Discretionary
- ASND Health Care
- Exchange
- MHK Nasdaq
- ASND Nasdaq
- Market Cap
- MHK 6.3B
- ASND 10.6B
- IPO Year
- MHK 1992
- ASND 2015
- Fundamental
- Price
- MHK $113.00
- ASND $175.45
- Analyst Decision
- MHK Buy
- ASND Strong Buy
- Analyst Count
- MHK 14
- ASND 17
- Target Price
- MHK $142.36
- ASND $222.18
- AVG Volume (30 Days)
- MHK 854.8K
- ASND 428.9K
- Earning Date
- MHK 07-24-2025
- ASND 09-02-2025
- Dividend Yield
- MHK N/A
- ASND N/A
- EPS Growth
- MHK N/A
- ASND N/A
- EPS
- MHK 7.66
- ASND N/A
- Revenue
- MHK $10,683,300,000.00
- ASND $398,509,511.00
- Revenue This Year
- MHK N/A
- ASND $77.19
- Revenue Next Year
- MHK $3.03
- ASND $75.84
- P/E Ratio
- MHK $14.69
- ASND N/A
- Revenue Growth
- MHK N/A
- ASND 12.06
- 52 Week Low
- MHK $96.24
- ASND $111.09
- 52 Week High
- MHK $164.29
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- MHK 62.47
- ASND 54.14
- Support Level
- MHK $106.91
- ASND $168.01
- Resistance Level
- MHK $115.80
- ASND $180.00
- Average True Range (ATR)
- MHK 3.12
- ASND 6.12
- MACD
- MHK 0.99
- ASND -0.28
- Stochastic Oscillator
- MHK 82.79
- ASND 59.33
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.